What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-03-31 compared with 2022-04-15 · 9 added, 141 removed, 6 unchanged (96% of the section changed)

for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

common stock, par value $0.001 per share (“Common Stock”), commenced trading on the Nasdaq Capital Market on January 2, 2008

under the symbol “DGLY,” and continues to do so.

From July 2007 until we became listed on the Nasdaq Capital Market, our

Common Stock was traded on the OTC Bulletin Board and prior to that it was quoted in the “Pink Sheets.”

Year Ended December 31, 2021

Year Ended December 31, 2020

of Common Stock

of April 15, 2022, we had approximately 171 shareholders of record for our Common Stock.

of Equity Securities

following table provides information regarding repurchases of our Common Stock during the quarter ended December 31, 2021.

Purchased (1)

Shares Purchased as

Part of Publicly

Approximate Dollar Value of

Shares that May Yet Be

Purchased Under the

December 2021

Total all plans

December 6, 2021, the Company announced that our board of directors (the “Board of Directors” or the “Board”)

approved a share repurchase program pursuant to which we may repurchase up to $10 million of our Common Shares.

repurchase program is set to expire on December 31, 2022.

Under the share repurchase program, the Company can repurchase its Common

Stock in the open market, through block trades, in privately negotiated transactions, pursuant to a trading plan.

open market repurchases of Common Stock may be made pursuant to trading plans established pursuant to Rule 10b5-1 under the

Exchange Act, which would permit Common Stock to be repurchased at a time that the Company might otherwise be precluded from

doing so under insider trading laws or self-imposed trading restrictions.

The actual timing, number and value of Common Stock

repurchased under the share repurchase program was determined by management at its discretion and depended on a number of factors,

including, but not limited to, the market price of our Common Stock, general market and economic conditions, our financial

condition, and applicable legal requirements.

We are not obligated to repurchase a minimum number of Common Stock under the

repurchase program.

date, we have not declared or paid cash dividends on our shares of Common Stock.

The holders of our Common Stock will be entitled to

non-cumulative dividends on the shares of Common Stock, when and as declared by our Board of Directors in its discretion.

We intend to retain all future earnings, if any, for our business and do not anticipate

paying cash dividends in the foreseeable future.

Holders of Common Stock

As of March 31, 2023, we had approximately 170 shareholders of record for

our Common Stock.

To date, we have not declared

or paid cash dividends on our shares of Common Stock.

The holders of our Common Stock will be entitled to non-cumulative dividends on

the shares of Common Stock, when and as declared by our board of directors (“Board of Directors” or “Board”) in

its discretion.

We intend to retain all future earnings, if any, for our business and do not anticipate paying cash dividends in the foreseeable

future determination to pay cash dividends will be at the discretion of our Board and will be dependent upon our financial condition,

results of operations, capital requirements, general business conditions and such other factors as our Board may deem relevant.

Authorized for Issuance under Equity Compensation Plans

Board of Directors adopted the 2005 Stock Option and Restricted Stock Plan (the “2005 Plan”) on September 1, 2005.

Plan authorized us to reserve 312,500 shares of our Common Stock for issuance upon exercise of options and grant of restricted stock

The 2005 Plan terminated in 2015 with 22,053 shares of Common Stock reserved for awards that are now unavailable for issuance.

Stock options granted under the 2005 Plan that remain unexercised and outstanding as of December 31, 2021 total 5,689.

January 17, 2006, our Board adopted the 2006 Stock Option and Restricted Stock Plan (the “2006 Plan”).

The 2006 Plan authorizes

us to reserve 187,500 shares of Common Stock for future grants under it.

The 2006 Plan terminated in 2016 with 39,974 shares of

Common Stock reserved for awards that are now unavailable for issuance.

Stock options granted under the 2006 Plan that remain unexercised

and outstanding as of December 31, 2021 total 25,625.

January 24, 2007, our Board adopted the 2007 Stock Option and Restricted Stock Plan (the “2007 Plan”).

The 2007 Plan authorizes

us to reserve 187,500 shares of Common Stock for future grants under it.

The 2007 Plan terminated in 2017 with 94,651 shares of

Common Stock reserved for awards that are now unavailable for issuance.

There are no stock options granted under the 2007 Plan that remain

unexercised and outstanding as of December 31, 2021.

January 2, 2008, our Board adopted the 2008 Stock Option and Restricted Stock Plan (the “2008 Plan”).

The 2008 Plan authorizes

us to reserve 125,000 shares of Common Stock for future grants under it.

The 2008 Plan terminated in 2018 with 40,499 shares of

Common Stock reserved for awards that are now unavailable for issuance.

There are no stock options granted under the 2008 Plan that remain

unexercised and outstanding as of December 31, 2021.

March 18, 2011, our Board adopted the 2011 Stock Option and Restricted Stock Plan (the “2011 Plan”).

The 2011 Plan authorizes

us to reserve 62,500 shares of Common Stock for future grants under it.

At December 31, 2021, there were 726 shares of Common Stock reserved

for awards available for issuance under the 2011 Plan.

Stock options granted under the 2011 Plan that remain unexercised and outstanding

as of December 31, 2021 total 9,750.

March 22, 2013, our Board adopted the 2013 Stock Option and Restricted Stock Plan (the “2013 Plan”).

The 2013 Plan was amended

on March 28, 2014 and November 14, 2014 to increase the number of shares of Common Stock authorized and reserved for issuance under the

2013 Plan to a total of 300,000.

At December 31, 2021, there were 100 shares of Common Stock reserved for awards available for issuance

under the 2013 Plan.

Stock options granted under the 2013 Plan that remain unexercised and outstanding as of December 31, 2021 total

March 27, 2015, our Board of Directors adopted the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”).

Plan was amended on February 25, 2016 and May 31, 2017 to increase the number of shares of Common Stock authorized and reserved for issuance

under the 2015 Plan to a total of 1,250,000.

At December 31, 2021, there were 3,686 shares of Common Stock reserved for awards available

for issuance under the 2015 Plan, as amended.

Stock options granted under the 2015 Plan that remain unexercised and outstanding as of

December 31, 2021 total 130,000.

April 12, 2018, our Board of Directors adopted the 2018 Stock Option and Restricted Stock Plan (the “2018 Plan”).

Plan was amended on May 21, 2019 to increase the number of shares of Common Stock authorized and reserved for issuance under the 2018

Plan to a total of 1,750,000.

At December 31, 2021, there were 625,500 shares of Common Stock reserved for awards available for issuance

under the 2018 Plan.

Stock options granted under the 2018 Plan that remain unexercised and outstanding as of December 31, 2021 total

Our Board of Directors adopted

the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”) on June 30, 2020 and the Company’s stockholders approved

the 2020 Plan at the Annual Meeting held on September 9, 2020.

The Company’s stockholders approved an amendment to the 2020 Plan

at the Annual Meeting held on June 22, 2021 which increased the number of shares of Common Stock authorized and reserved for issuance

under the 2020 Plan to a total of 2,500,000.

At December 31, 2021, there were 915,845 shares of Common Stock reserved for

awards available for issuance under the 2020 Plan.

Stock options granted under the 2020 Plan that remain unexercised and outstanding

as of December 31, 2021 total 555,000.

2005 Plan, 2006 Plan, 2007 Plan, 2008 Plan, 2011 Plan, 2013 Plan, 2015 Plan, 2018 Plan, and 2020 Plan are collectively referred to as

Plans authorize us to grant (i) to the key employees incentive stock options (except for the 2007 Plan) to purchase shares of Common

Stock and non-qualified stock options to purchase shares of Common Stock and restricted stock awards, and (ii) to non-employee directors

and consultants’ non-qualified stock options and restricted stock.

The Compensation Committee of our Board (the “Compensation

Committee”) administers the Plans by making recommendations to the Board or determinations regarding the persons to whom options

or restricted stock should be granted and the amount, terms, conditions and restrictions of the awards.

Plans allow for the grant of incentive stock options (except for the 2007 Plan), non-qualified stock options and restricted stock awards.

Incentive stock options granted under the Plans must have an exercise price at least equal to 100% of the fair market value of the Common

Stock as of the date of grant.

Incentive stock options granted to any person who owns, immediately after the grant, stock possessing

more than 10% of the combined voting power of all classes of our stock, or of any parent or subsidiary corporation, must have an exercise

price at least equal to 110% of the fair market value of the Common Stock on the date of grant.

Non-statutory stock options may have

exercise prices as determined by our Compensation Committee.

Compensation Committee is also authorized to grant restricted stock awards under the Plans.

A restricted stock award is a grant of shares

of the Common Stock that is subject to restrictions on transferability, risk of forfeiture and other restrictions and that may be forfeited

in the event of certain terminations of employment or service prior to the end of a restricted period specified by the Compensation Committee.

have filed various registration statements on Form S-8 and amendments to previously filed Form S-8’s with the Securities and Exchange

Commission (the “SEC”), which registered a total of 5,675,000 shares of Common Stock issued or to be issued upon exercise

of the stock options underlying Plans.

following table sets forth certain information regarding the Plans as of December 31, 2021:

Compensation Plan Information

Plan category

securities to be

options, warrants

and rights (a)

Weighted-average

exercise price of

options, warrants

and rights (b)

available for

future issuance

plans (excluding

securities reflected

in column (a)) (c)

Equity compensation plans approved

by stockholders

Equity compensation

plans not approved by stockholders

Sales of Unregistered Securities

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity